V
主页
Utilizing the Gibco CTS Rotea System for cell and gene therapy development
发布人
打开封面
下载高清视频
观看高清视频
视频下载器
Industrialization of Cell Therapy Manufacturing
Cell therapy logistics_ Exploring the last 100m
High-Quality Plasmid DNA Manufacturing Strategies for Gene and Cell Therapeutics
GMP requirements for cell and gene therapy institutions
Removing analytical bottlenecks in cell therapy
CAR-T Cell Therapy_ Now and in 2030
Meeting Regulatory Requirements for Cell and Gene Therapy Manufacturing
2022 WMIF,Cell Therapy and Transplantation for Parkinson'sease
2022 WMIF,The Cell Therapy Landscape,CAR-T to Stem Cells
Stem Cell Therapie's Potential in the Pandemic Era
Understanding & predicting outcomes in CAR T-cell therapy
Off-the-shelf NK cell therapy [WEBINAR]
How cell and gene therapies can transform the treatment of solid tumours
Simplifying GMP CAR T and CAR NK cell therapy manufacturing processes
Addressing the challenges of cell and gene therapy manufacturing
A CRISPR Vision for the Future of Cell Therapy
All you need for T cell research
GMP Raw Materials for Cell Therapy - What, When, How?
Keynote_ Carl June | Therapy Gladstone-UCSF
CAR-T Generation for Identity, Purity and Potency Assay Testing
VHP气相灭菌技术
湿热灭菌的科学原理
基因治疗药物的CMC开发策略
A cGMP Compatible, Non-Viral CAR T Cell Manufacturing Process
计算机化系统GMP要求
实验室记录与数据管理
Blocking ADAM17 as a therapeutic approach to increase human NK cell proliferatio
High Cell Density and Perfusion Process Solutions
QA人员现场管理
Lentivirus vector manufacturing using suspension cell line
温度分布验证相关考虑
CFDI《细胞质量产品GMP指南》解读
细胞库GMP管理要求
稳定性试验的条件和具体实施要点和要求
Dr. Carl June Presenting at Nobel Conference
公用工程系统GMP合规性
消毒技术
生物制药的GMP检查要求
生物制药质量管理
FT596_ iPSC-derived CAR-NK cells with engineered persistence for B-cell malignan